About Ash
Ash is a company based in New York (United States) founded in 2019 by Kyle Waters, David Stein, Emma Jean Rayner, Mio Akasako, and Nick Sempere. It operates as a HealthTech and Direct-to-Consumer (D2C). Ash has raised $47.47 million across 2 funding rounds. Ash offers products and services including At-Home Health Testing Platform, Cancer Screening Kits, and Chronic Conditions Management. Ash operates in a competitive market with competitors including Color, Unite Us, Biobot Analytics, Metabiota and Azara Healthcare, among others.
- Headquarter New York, United States
- Founders Kyle Waters, David Stein, Emma Jean Rayner, Mio Akasako, Nick Sempere
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ash Wellness
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$47.47 M (USD)
in 2 rounds
-
Latest Funding Round
$40 M (USD), Series A
Nov 05, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ash
Ash offers a comprehensive portfolio of products and services, including At-Home Health Testing Platform, Cancer Screening Kits, and Chronic Conditions Management.
Customizable at-home testing solutions are provided for organizations.
Early detection kits for cancer are offered to patients.
Testing for chronic conditions is supported for patients.
People of Ash
Unlock access to complete
Funding Insights of Ash
Ash has successfully raised a total of $47.47M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $40 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Ash
Investment portfolio details for Ash
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ash
Detailed financials for Ash
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ash Comparisons
Peer comparison for Ash
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ash
Ash operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Color, Unite Us, Biobot Analytics, Metabiota and Azara Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Cloud-based software for patient interoperability and community management is offered.
|
|
| Locked | Locked | Locked |
Tools are provided to map microbes and chemicals of interest.
|
|
| Locked | Locked | Locked |
Epidemic outbreaks are predicted and controlled through risk analytics.
|
|
| Locked | Locked | Locked |
Population health management is enabled via cloud-based tools for hospitals.
|
Detailed competitors of Ash
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ash
Complete news archive for Ash
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ash
Ash was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Ash is headquartered in New York, United States. It is registered at New York, New York, United States.
David Stein is the current CEO of Ash. They have also founded this company.
Ash is a funded company, having raised a total of $47.47M across 2 funding rounds to date.
At-home health testing programs are developed by Ash for health plans, digital health companies, and public health organizations. Services are focused on closing care gaps, managing chronic conditions, and providing screenings for cancer, infectious diseases, and hormonal health. Customizable and white-label solutions are offered to improve patient engagement and access to preventive care across the United States. A robust lab network and technology platform are utilized to ensure seamless integration and real-time reporting. Sectors served include healthcare and digital health with an emphasis on transforming clinical outcomes and HEDIS measures.
Ash's top competitors include Biobot Analytics, Unite Us and Metabiota.
Ash offers At-Home Health Testing Platform, Cancer Screening Kits, and Chronic Conditions Management.